Table: Taiko Pharmaceutical -2023 parent results
Feb 9 (Reuters)-
Taiko Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2023 Dec 31, 2022 Dec 31, 2024 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 5.43 4.64
(+16.9 pct)
Operating loss 1.04 loss 2.96
Recurring loss 1.33 loss 3.27
Net loss 3.72 loss 4.95
EPS loss 78.63 yen loss 113.64 yen
Ann Div NIL NIL
-Q2 Div NIL NIL
-Q4 Div NIL NIL
NOTE - Taiko Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T